CAS 14769-73-4|(S)-(-)-Levamisole
Introduction:Basic information about CAS 14769-73-4|(S)-(-)-Levamisole, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | (S)-(-)-Levamisole | ||
|---|---|---|---|
| CAS Number | 14769-73-4 | Molecular Weight | 204.291 |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 344.4±45.0 °C at 760 mmHg |
| Molecular Formula | C11H12N2S | Melting Point | 230 - 233ºC |
| MSDS | / | Flash Point | 162.1±28.7 °C |
Names
| Name | levamisole |
|---|---|
| Synonym | More Synonyms |
(S)-(-)-Levamisole BiologicalActivity
| Description | (S)-(-)-Levamisole (Levamisole), an anthelmintic agent with immunomodulatory properties. (S)-(-)-Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active[1][2]. |
|---|---|
| Related Catalog | Research Areas >>InfectionSignaling Pathways >>Membrane Transporter/Ion Channel >>nAChRSignaling Pathways >>Neuronal Signaling >>nAChRResearch Areas >>Inflammation/Immunology |
| In Vivo | (S)-(-)-Levamisole (Levamisole) (50 μg/ml and 200 μg/ml; p.o.; 30 days) prevents weight gain in mice that were fed a high fat diet[2]. |
| References | [1]. Lewis JA, et al. Levamisole: A Positive Allosteric Modulator for the α3β4 Nicotinic Acetylcholine Receptors Prevents Weight Gain in the CD-1 Mice on a High Fat Diet. Curr Pharm Des. 2017;23(12):1869-1872. [2]. Mehta KP, et al. Immunoregulatory treatment for minimal change nephrotic syndrome. Arch Dis Child. 1986;61(2):153-158. |
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 344.4±45.0 °C at 760 mmHg |
| Melting Point | 230 - 233ºC |
| Molecular Formula | C11H12N2S |
| Molecular Weight | 204.291 |
| Flash Point | 162.1±28.7 °C |
| Exact Mass | 204.072113 |
| PSA | 40.90000 |
| LogP | 1.85 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.713 |
| InChIKey | HLFSDGLLUJUHTE-SNVBAGLBSA-N |
| SMILES | c1ccc(C2CN3CCSC3=N2)cc1 |
| Storage condition | 0-6°C |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 480 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 120 mg/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 24 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 210 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 84 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 22 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 700 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 15 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
- TYPE OF TEST :
- Cytogenetic analysis
MUTATION DATA - TEST SYSTEM :
- Human
- DOSE/DURATION :
- 2142 ug/kg
- REFERENCE :
- PTBIAN Pathologie Biologie. (Expansion Scientifique Francaise, 15, rue St. Benoit, F-75278 Paris Cedex 06, France) V.17- 1969- Volume(issue)/page/year: 28,323,1980 *** REVIEWS *** TOXICOLOGY REVIEW PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 2,407,1979
- TEST SYSTEM :
- Human
- DOSE/DURATION :
- 2142 ug/kg
- REFERENCE :
- PTBIAN Pathologie Biologie. (Expansion Scientifique Francaise, 15, rue St. Benoit, F-75278 Paris Cedex 06, France) V.17- 1969- Volume(issue)/page/year: 28,323,1980 *** REVIEWS *** TOXICOLOGY REVIEW PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 2,407,1979
Safety Information
| Hazard Codes | Xi |
|---|---|
| RIDADR | UN 2811 |
| HS Code | 2934999090 |
Customs
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |
Synonyms
| MFCD00792481 |
| 6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole |
| Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl- |
| levomysol |
| L-teramisole |
| 6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole |
| lepuron |
| UNII:C8M7RFE4NO |
| (±)-Tetramisole |
| dl-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole |
| 6-Phenyl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazole |
| dl-Tetramisol |
| LEVAMISOLE BASE |
| EINECS 238-836-5 |
| Tetramisole |
| 2,3,5,6-Tetrahydro-6-phenyl-imidazo(2,1-b)thiazole |
| Levamisole |
| Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl- |
| dl-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazole |
| (±)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole |
| (±)-2,3,5,6-Tetrahydro-6-phenylimidazo(2,1-b)thiazole |
| Ketrax |
| dl-Tetramisole |
| Nilverm base |
| Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (±)- |
| tetramizole |
| l-tetramisole |
